| Name | Title | Contact Details |
|---|
When Ginger co-founder and COO, Karan Singh, was young, his mother would brew him ginger tea when she could sense that he was about to get sick. A preventative health remedy that originates from Southeast Asia, the ginger root is commonly used at the first sign of illness, before things get worse. Similar to this approach, the Ginger system takes a preventative approach to mental health, addressing issues before they evolve into greater challenges and providing support anywhere, at any time. By bringing the power of on-demand mental health support to hundreds of thousands of people globally, we continue to advance our mission of creating a world where mental health is never an obstacle.
Business Health Services is a Baltimore, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Nimble journey began with a loved one who was sick. I found myself visiting the pharmacy multiple times per week rather than caring for my family member. This inspired me to build a different approach – an experience that centered around the patient`s needs and the provider`s workflow. My goal was that customers would LOVE the experience so much that they would tell the world about it.
Alnylam is the world`s leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market. We are developing RNAi (RNA interference) as an innovative, entirely new class of medicines to treat rare genetic, cardio metabolic, acute hepatic infectious and central nervous system (CNS) and ocular diseases. Alnylam was founded in 2002 based on a Nobel Prize-winning breakthrough in biology – the discovery of RNAi, and a bold vision that this discovery could be used to silence disease-causing genes upstream of today`s medicines. We are relentless in our pursuit of new treatments because we believe that RNAi therapeutics can be used to treat many diseases for which treatment options do not exist or are inadequate. Overall, we believe that patients shouldn`t have to wait for hope. Alnylam is turning scientific possibility into reality - in 2018, the FDA and European EMA approved of our first product, ONPATTRO (patisiran) which is also the first-ever approved RNAi therapeutic. In 2019, the FDA approved our second product, GIVLAARI (givosiran). Our robust pipeline of investigational medicines includes multiple programs in late-stage and early-stage clinical development. We are a global and diverse company of more than 1,500 people. We pride ourself on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That`s why we`ve been named a Science Magazine Top Employer for two years in a row (`19-`20), a Boston Globe Top Place to Work 5x in a row (`15-`19) and one of Fast Company`s 50 Most Innovative Companies for 2019. We are based in Cambridge, U.S., with offices throughout Europe, Asia and South America.
Founded by identical twins, Rose Cook and Lynn Faughey, The FlexPro Group is a specialty consulting firm, focused on delivering project management expertise to companies in the Life Sciences. Since 2008, FlexPro has been recognized as a premier provider of project management consulting services to this industry. For the 3rd year in a row, FlexPro was recognized by Inc. Magazine as one of America`s fastest-growing private companies: #859 (2014), #288 (2013) and #104 (2012). Also ranked 6th on the Philadelphia 100 lists of fastest growing privately-held companies (both in 2013 and 2012). Ranked among the Top 25 Management Consulting Firms in Philadelphia Business Journal`s "The List" (2017).